Parametric Portfolio Associates’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	$1.16M	Buy	52,656 +39,096	+288%	+$858K	﹤0.01%	2714
2021 Q4	$385K	Buy	13,560 +1,537	+13%	+$43.6K	﹤0.01%	3176
2021 Q3	$253K	Buy	+12,023	New	+$253K	﹤0.01%	3365